Clin2
NCT07655154Likely a fitNot yet recruiting

Quick sepsis diagnosis study using biomarkers

Sepsis

Part of Infections clinical trials.

This trial is testing whether certain biomarkers (substances in your body) can help diagnose sepsis faster. Sepsis is a serious condition where your body has a severe response to an infection. The study will look at blood or other samples to see if these markers can quickly tell if you have sepsis, which could lead to faster treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
2 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You must be at least 18 years old.
  • You must have organ dysfunction, which is a sudden drop in your organ function (measured by a score called SOFA).
  • A sample (like blood, urine, or other fluid) must have been collected to check for infection.
  • You (or a legal guardian) must sign a consent form agreeing to be in the study.
  • You cannot have had a recent injury (like from an accident or fall).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06253325Recruiting
Early detection of patients at risk for sepsis

This trial is looking for patients who have an infection and are showing early signs of getting sicker, like a high warning score. It aims to find out if doctors can identify those at risk of sepsis sooner so they can start treatment earlier.

Southampton, Hampshire
NCT07543497Not yet recruiting
Testing a new blood test to identify sepsis early

This trial tests a new blood test called the Sepsis ImmunoScore that may help doctors quickly identify sepsis (a life-threatening infection response). The test looks at your immune system's response to see if you have sepsis, which could help you get treatment faster.

NCT06745115Recruiting
Using blood fluorescence to detect sepsis

This trial tests a new way to detect sepsis using fluorescence from a blood sample. It may help doctors identify sepsis earlier and improve treatment.

Guangzhou, Guangdong
NCT06028178Not yet recruiting
Early warning of sepsis using a new blood test

This trial is testing whether a new, highly sensitive blood test (droplet digital PCR) combined with genetic analysis can help doctors predict sepsis earlier in emergency room patients. This could lead to faster treatment and better outcomes.

NCT06689189Recruiting
Detecting sepsis early with blood fluorescence

This trial uses a blood fluorescence test to check for early signs of sepsis. It may help doctors diagnose sepsis faster, allowing for quicker treatment.

Ningbo, Zhejiang
NCT06178822Recruiting
New blood tests to diagnose sepsis in the ER

This study aims to find new ways to quickly diagnose sepsis (a severe response to infection) in patients arriving at the emergency room. If successful, these new tests could help doctors start treatment faster.

Almere Stad, Flevoland

Hear when a new Sepsis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.